Effects of a 12-wk whole-body vibration based intervention to improve type 2 diabetes

No Thumbnail Available
Authors
del Pozo-Cruz, Borja
Alfonso-Rosa, Rosa M.
del Pozo-Cruz, Jesus
Sanudo Corrales, Borja
Rogers, Michael E.
Advisors
Issue Date
2014-01
Type
Article
Keywords
Glycemic control , Diabetic patients , Vibration therapy , Exercise therapy , Prevention therapy
Research Projects
Organizational Units
Journal Issue
Citation
del Pozo-Cruz, Borja; Alfonso-Rosa, Rosa M.; del Pozo-Cruz, Jesus; Sanudo, Borja; Rogers, Michael E. 2014. Effects of a 12-wk whole-body vibration based intervention to improve type 2 diabetes. Maturitas, vol. 77:no. 1:ppg. 52–58
Abstract

Objective: To test the feasibility, safety and effectiveness of a 12-wk whole body vibration (WBV) intervention on glycemic control, lipid-related cardiovascular risk factors and functional capacity among type 2 diabetes mellitus (T2DM) patients in a primary care context.

Methods: Fifty non-insulin dependent T2DM patients were randomized 1:1 to an intervention group that, in addition to standard care, received a 12-wk WBV intervention, and a control group receiving only standard care (from February 2012 through May 2012). Outcomes, including glycated hemoglobin (HbA1c), fasting blood glucose, lipid-related cardiovascular risk factors (i.e., cholesterol, triglycerides, lipoproteins, LDL/HDL and atherogenic index) and functional capacity were measured at baseline and after the 12-wk intervention.

Results: After intervention, there was a reduction in HbA1c and fasting blood glucose when compared to the control group, with a mean difference in change scores between groups of -0.55% (95% CI -0.15 to -0.76) and -33.95 mm/dl (95% CI -51.38 to -3.47), respectively. Similarly, most lipid-related cardiovascular risk factors (i.e., cholesterol, triglycerides and atherogenic index) were also reduced (p < 0.05).

Conclusion:A 1 2-wk WBV intervention in a primary care context is feasible, safe and effective in improving glycemic profile, lipid-related cardiovascular risk factors and functional capacity among T2DM patients.

Table of Contents
Description
Click on the DOI link to access the article (may not be free).
Publisher
Elsevier Ireland Ltd
Journal
Book Title
Series
Maturitas;v.77:no.1
PubMed ID
DOI
ISSN
0378-5122
EISSN